Rise Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.55K Hold
84
﹤0.01% 1020
2025
Q1
$8.83K Buy
+84
New +$8.83K ﹤0.01% 1065